Cite
Long–Term Disease Control After Allogeneic Hematopoietic Stem Cell Transplantation in Primary Cutaneous T–Cell Lymphoma; Results From a Single Institution Analysis
MLA
Florentia Dimitriou, et al. “Long–Term Disease Control After Allogeneic Hematopoietic Stem Cell Transplantation in Primary Cutaneous T–Cell Lymphoma; Results From a Single Institution Analysis.” Frontiers in Medicine, vol. 7, June 2020. EBSCOhost, https://doi.org/10.3389/fmed.2020.00290.
APA
Florentia Dimitriou, Urs Schanz, Gayathri Nair, Susanne Kimeswenger, Marie-Charlotte Brüggen, Wolfram Hoetzenecker, Lars E. French, Reinhard Dummer, Antonio Cozzio, & Emmanuella Guenova. (2020). Long–Term Disease Control After Allogeneic Hematopoietic Stem Cell Transplantation in Primary Cutaneous T–Cell Lymphoma; Results From a Single Institution Analysis. Frontiers in Medicine, 7. https://doi.org/10.3389/fmed.2020.00290
Chicago
Florentia Dimitriou, Urs Schanz, Gayathri Nair, Susanne Kimeswenger, Marie-Charlotte Brüggen, Wolfram Hoetzenecker, Lars E. French, Reinhard Dummer, Antonio Cozzio, and Emmanuella Guenova. 2020. “Long–Term Disease Control After Allogeneic Hematopoietic Stem Cell Transplantation in Primary Cutaneous T–Cell Lymphoma; Results From a Single Institution Analysis.” Frontiers in Medicine 7 (June). doi:10.3389/fmed.2020.00290.